EPISODE · Apr 5, 2019 · 11 MIN
A new drug for short bowel syndrome
from Listen to The Lancet Gastroenterology & Hepatology · host The Lancet
Dr Rahim Naimi discusses the results of a phase 2 trial of glepaglutide to treat short bowel syndrome.
Embed this episode
NOW PLAYING
A new drug for short bowel syndrome
0:00
11:13
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Listen to The Lancet Gastroenterology & Hepatology?
This episode is 11 minutes long.
When was this Listen to The Lancet Gastroenterology & Hepatology episode published?
This episode was published on April 5, 2019.
Can I download this Listen to The Lancet Gastroenterology & Hepatology episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!